5-fluorouracil enhances the antitumor effect of sorafenib and sunitinib in a xenograft model of human renal cell carcinoma

Sorafenib and sunitinib are multi-kinase inhibitors with antitumor activity in patients with advanced renal cell carcinoma (RCC). Several studies have evaluated the effect of sorafenib/sunitinib in combination with chemotherapeutic agents in different types of tumor. However, few studies have addres...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: MIYAKE, MAKITO, ANAI, SATOSHI, FUJIMOTO, KIYOHIDE, OHNISHI, SAYURI, KUWADA, MASAOMI, NAKAI, YASUSHI, INOUE, TAKESHI, TOMIOKA, ATSUSHI, TANAKA, NOBUMICHI, HIRAO, YOSHIHIKO
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: D.A. Spandidos 2012
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3392575/
https://ncbi.nlm.nih.gov/pubmed/22783417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2012.662
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg